powered by a patent pending risk model
September 25, 2013
SafeUseNow℠ Selected as a
Knight News Challenge Winner
SafeUseNow℠ is a winner of the 2014 Knight News Challenge: Health. Principled Strategies' submission: A Solution for California's Medicaid Plans to Reduce the Risk and Cost of Prescription Drug Abuse, was one of seven winners selected from among nearly 700 entries.
The announcement was made by Michael Maness, Knight Foundation Vice President, Journalism & Media Innovation at the Clinton Foundation 2014 Health Matters conference in La Quinta, CA.
News Alert: Principled Strategies and Precision Diagnostics Announce Partnership to Proactively Address Prescription Drug Abuse, Misuse, and Diversion.
SafeUseNow is a risk identification and intervention solution developed by Principled Strategies, a health care consultancy with expertise in predictive analytics, optimization, and risk analysis.
The SafeUseNow advantage is predictive risk factors discovered in a national, multiyear study of physician prescribing, pharmacy dispensing, and patient utilization of controlled substances. The result? An actionable solution for systematically and efficiently combating the misuse, abuse, addiction and diversion of controlled substance drugs.
Private Health Insurance Plans
Public Health Insurance Plans
Pharmacy Benefit Managers
Workers' Compensation Funds
Hospitals and Clinics
Medical and Pharmacy Boards
Medical Malpractice Carriers
Benefits/Talent/Risk Management Companies
Pharmaceutical Supply Chain
21st Annual PBMI Drug Benefit Conference
Westin Mission Hills Golf Resort & Spa
Feb 29 - Mar 2, 2016 ▪ Palm Springs, CA
Kick off with an innovative keynote speech by Dr. Daniel Kraft. Dr. Kraft, a progressive physician, will examine rapidly emerging, game changing, and convergent technology trends and how they are and will be leveraged to change the face of health care and the practice of medicine in the next decade.
Come see our joint presentation with Precision Diagnostics for a SafeUseNow App Demo!
Track 3 - Wednesday Mar 2 - 9:40a-10:40a